Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: This study investigated whether serum bilirubin levels can predict the progression of carotid atherosclerosis in individuals with type 2 diabetes mellitus (T2DM). Methods: This observational study included 1,381 subjects with T2DM in whom serial measurements of carotid intima-media thickness (CIMT) were made at 1- to 2-year intervals for 6–8 years. The progression of carotid atherosclerosis was defined as newly detected plaque lesions on repeat ultrasonography. After dividing total serum bilirubin levels into tertiles, the association between total serum bilirubin at baseline and plaque progression status was analyzed. Results: Among 1,381 T2DM patients, 599 (43.4%) were categorized as having plaque progression in their carotid arteries. Those with plaque progression were significantly older; showed a higher prevalence of hypertension, abdominal obesity, and chronic kidney disease; and had a longer duration of T2DM, higher levels of total cholesterol (TC), triglycerides, and insulin resistance, and lower total bilirubin concentrations than those with no plaque progression. When total serum bilirubin levels were divided into tertiles, the highest tertile group was younger than the lowest tertile group, with higher levels of TC and high-density lipoprotein cholesterol. Multiple logistic regression analysis demonstrated that higher serum bilirubin levels were associated with a significantly lower risk of CIMT progression (odds ratio, 0.584; 95% confidence interval, 0.392–0.870; p=0.008). Age (p<0.001), body mass index (p=0.023), and TC (p=0.019) were also associated with the progression of carotid atherosclerosis in T2DM patients. Conclusion: Total serum bilirubin is independently associated with progression of atherosclerosis in the carotid arteries in T2DM patients.
Abstract
Objective: This study investigated whether serum bilirubin levels can predict the progression of carotid atherosclerosis in individuals with type 2 diabetes mellitus (T2DM). Methods: This observational study included 1,381 subjects with T2DM in whom serial measurements of carotid intima-media thickness (CIMT) were made at 1- to 2-year intervals for 6–8 years. The progression of carotid atherosclerosis was defined as newly detected plaque lesions on repeat ultrasonography. After dividing total serum bilirubin levels into tertiles, the association between total serum bilirubin at baseline and plaque progression status was analyzed. Results: Among 1,381 T2DM patients, 599 (43.4%) were categorized as having plaque progression in their carotid arteries. Those with plaque progression were significantly older; showed a higher prevalence of hypertension, abdominal obesity, and chronic kidney disease; and had a longer duration of T2DM, higher levels of total cholesterol (TC), triglycerides, and insulin resistance, and lower total bilirubin concentrations than those with no plaque progression. When total serum bilirubin levels were divided into tertiles, the highest tertile group was younger than the lowest tertile group, with higher levels of TC and high-density lipoprotein cholesterol. Multiple logistic regression analysis demonstrated that higher serum bilirubin levels were associated with a significantly lower risk of CIMT progression (odds ratio, 0.584; 95% confidence interval, 0.392–0.870; p=0.008). Age (p<0.001), body mass index (p=0.023), and TC (p=0.019) were also associated with the progression of carotid atherosclerosis in T2DM patients. Conclusion: Total serum bilirubin is independently associated with progression of atherosclerosis in the carotid arteries in T2DM patients.
참고문헌 (36)
- Zheng Y, "Global aetiology and epidemiology of type 2 diabetes mellitus and its complications", Nat Rev Endocrinol, 14, pp.88~98 (2018)
- Emerging Risk Factors Collaboration, "Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease : a collaborative meta-analysis of 102 prospective studies", Lancet, 375, pp.2215~2222 (2010)
- Kim SK, "Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance", J Clin Endocrinol Metab, 99, pp.1879~1884 (2014)
- 한유진, "Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases", Diabetes and Metabolism Journal, 41(6), pp.430~437 (2017), 대한당뇨병학회[DOI]
- Lee EY, "Association between heme oxygenase-1 promoter polymorphisms and the development of albuminuria in type 2 diabetes: a case-control study", Medicine(Baltimore), 94, pp.e1825~ (2015)
- Schwertner HA, "Association of low serum concentration of bilirubin with increased risk of coronary artery disease", Clin Chem, 40, pp.18~23 (1994)
- Hamur H, "Total bilirubin levels predict subclinical atherosclerosis in patients with prediabetes", Angiology, 67, pp.909~915 (2016)
- Dullaart RP, "Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects", Clin Chim Acta, 414, pp.161~165 (2012)
- Kawamoto R, "Mildly elevated serum total bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons with type 2 diabetes", Clin Exp Hypertens, 38, pp.107~112 (2016)
- Choe EY, "Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes", J Gastroenterol Hepatol, 33, pp.1082~1091 (2018)
- American Diabetes Association, "2. Classification and diagnosis of diabetes : Standards of Medical Care in Diabetes-2019", Diabetes Care, 42, pp.S13~S28 (2019)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation", Ann Intern Med, 130, pp.461~470 (1999)
- Sharma R, "Comparison of short insulin tolerance test with HOMA Method for assessment of insulin sensitivity in Asian Indians in north India", Diabetes Res Clin Pract, 82, pp.e9~e12 (2008)
- 이미영, "Short Insulin Tolerance Test Can Determine the Effects of Thiazolidinediones Treatment in Type 2 Diabetes", Yonsei Medical Journal, 49(6), pp.901~908 (2008), 연세대학교의과대학
- Qi Y, "Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population : a community-based cohort study", J Am Coll Cardiol, 65, pp.355~363 (2015)
- Hopkins PN, "Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease", Arterioscler Thromb Vasc Biol, 16, pp.250~255 (1996)
- Kimm H, "Low serum bilirubin level as an independent predictor of stroke incidence : a prospective study in Korean men and women", Stroke, 40, pp.3422~3427 (2009)
- Perlstein TS, "Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease : National Health and Nutrition Examination Survey(NHANES)1999 to 2004", Arterioscler Thromb Vasc Biol, 28, pp.166~172 (2008)
- Kunutsor SK, "Circulating total bilirubin and risk of incident cardiovascular disease in the general population", Arterioscler Thromb Vasc Biol, 35, pp.716~724 (2015)
- Kim ES, "Inverse association between serum bilirubin levels and arterial stiffness in Korean women with type 2 diabetes", PLoS One, 9, pp.e109251~ (2014)
- Ren Y, "Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes", Sci Rep, 6, pp.36437~ (2016)
- Rosvall M, "Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period : the Malmö Diet and Cancer Study", Atherosclerosis, 239, pp.615~621 (2015)
- Herder M, "Risk factors for progression of carotid intima-media thickness and total plaque area : a 13-year follow-up study : the Tromsø Study", Stroke, 43, pp.1818~1823 (2012)
- Bosevski M, "Progression of carotid-artery disease in type 2 diabetic patients : a cohort prospective study", Vasc Health Risk Manag, 11, pp.549~553 (2015)
- Yamasaki Y, "Carotid intima-media thickness in Japanese type 2 diabetic subjects : predictors of progression and relationship with incident coronary heart disease", Diabetes Care, 23, pp.1310~1315 (2000)
- Clark JE, "Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress", Biochem J, 348, pp.615~619 (2000)
- Dennery PA, "Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia", Free Radic Biol Med, 19, pp.395~404 (1995)
- Morita T, "Induction of heme oxygenase-1 in monocytes suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2 : role of bilirubin and carbon monoxide generated by the enzyme", Antioxid Redox Signal, 5, pp.439~447 (2003)
- Mazzone GL, "Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules", Biochem Biophys Res Commun, 386, pp.338~344 (2009)
- Mazzone GL, "Bilirubin effect on endothelial adhesion molecules expression is mediated by the NF-kappaB signaling pathway", Biosci Trends, 3, pp.151~157 (2009)
- Ollinger R, "Bilirubin : a natural inhibitor of vascular smooth muscle cell proliferation", Circulation, 112, pp.1030~1039 (2005)
- Peyton KJ, "Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration", Front Pharmacol, 3, pp.48~ (2012)
- O'Kane MJ, "Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis", Atherosclerosis, 131, pp.203~210 (1997)
- Levinson SS, "Relationship between bilirubin, apolipoprotein B, and coronary artery disease", Ann Clin Lab Sci, 27, pp.185~192 (1997)
- Yet SF, "Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling", FASEB J, 17, pp.1759~1761 (2003)
- Duckers HJ, "Heme oxygenase-1 protects against vascular constriction and proliferation", Nat Med, 7, pp.693~698 (2001)